Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1999 Jan;229(1):1–10. doi: 10.1097/00000658-199901000-00001

Growth hormone, alone and in combination with insulin, increases whole body and skeletal muscle protein kinetics in cancer patients after surgery.

R S Berman 1, L E Harrison 1, D B Pearlstone 1, M Burt 1, M F Brennan 1
PMCID: PMC1191602  PMID: 9923794

Abstract

OBJECTIVE: To investigate the impact of growth hormone, alone and in combination with insulin, on the protein kinetics of patients with upper gastrointestinal (GI) tract cancer who have undergone surgery and are receiving total parenteral nutrition (TPN). SUMMARY BACKGROUND DATA: Patients with malignancies of the upper GI tract are at increased risk for malnutrition and perioperative death and complications. Standard nutritional support has not significantly altered outcome. Growth hormone (GH) and insulin have been shown to have some benefit in patients with cancer; however, their action in patients undergoing resection has not previously been studied. METHODS: Thirty patients undergoing surgery for upper GI tract malignancies were prospectively randomized into one of three nutritional support groups after surgery: 10 patients received standard TPN, 10 received TPN plus daily injections of GH, and 10 received daily GH, systemic insulin, and TPN. The patients underwent a protein kinetic radiotracer study on the fifth day after surgery to determine whole body and skeletal muscle protein kinetics. RESULTS: Patients who received standard TPN only were in a state of negative skeletal muscle protein net balance. Those who received GH and insulin had improved skeletal muscle protein net balance compared with the TPN only group. Whole body protein net balance was improved in the GH and the GH and insulin groups compared with the TPN only group. GH and insulin combined did not improve whole body net balance more than GH alone. GH administration significantly increased serum IGF-1 and GH levels. Insulin infusion significantly increased serum insulin levels and the insulin/glucagon ratio. CONCLUSION: Growth hormone and GH plus insulin regimens improve protein kinetic parameters in patients with upper GI tract cancer who are receiving TPN after undergoing surgery.

Full text

PDF
10

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akaza H., Matsuki K., Matsushima H., Koiso K., Aso Y. Stimulatory effects of growth hormone on rat bladder carcinogenesis. Cancer. 1991 Dec 1;68(11):2418–2421. doi: 10.1002/1097-0142(19911201)68:11<2418::aid-cncr2820681115>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  2. Allsop J. R., Wolfe R. R., Burke J. F. Tracer priming the bicarbonate pool. J Appl Physiol Respir Environ Exerc Physiol. 1978 Jul;45(1):137–139. doi: 10.1152/jappl.1978.45.1.137. [DOI] [PubMed] [Google Scholar]
  3. Barrett E. J., Revkin J. H., Young L. H., Zaret B. L., Jacob R., Gelfand R. A. An isotopic method for measurement of muscle protein synthesis and degradation in vivo. Biochem J. 1987 Jul 1;245(1):223–228. doi: 10.1042/bj2450223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blethen S. L., Allen D. B., Graves D., August G., Moshang T., Rosenfeld R. Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience. J Clin Endocrinol Metab. 1996 May;81(5):1704–1710. doi: 10.1210/jcem.81.5.8626820. [DOI] [PubMed] [Google Scholar]
  5. Brennan M. F., Pisters P. W., Posner M., Quesada O., Shike M. A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg. 1994 Oct;220(4):436–444. doi: 10.1097/00000658-199410000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brennan M. F. Uncomplicated starvation versus cancer cachexia. Cancer Res. 1977 Jul;37(7 Pt 2):2359–2364. [PubMed] [Google Scholar]
  7. Burt M. E., Stein T. P., Schwade J. G., Brennan M. F. Whole-body protein metabolism in cancer-bearing patients. Effect of total parenteral nutrition and associated serum insulin response. Cancer. 1984 Mar 15;53(6):1246–1252. doi: 10.1002/1097-0142(19840315)53:6<1246::aid-cncr2820530605>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  8. Byrne T. A., Morrissey T. B., Gatzen C., Benfell K., Nattakom T. V., Scheltinga M. R., LeBoff M. S., Ziegler T. R., Wilmore D. W. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation. Ann Surg. 1993 Oct;218(4):400–418. doi: 10.1097/00000658-199310000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dewys W. D., Begg C., Lavin P. T., Band P. R., Bennett J. M., Bertino J. R., Cohen M. H., Douglass H. O., Jr, Engstrom P. F., Ezdinli E. Z. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980 Oct;69(4):491–497. doi: 10.1016/s0149-2918(05)80001-3. [DOI] [PubMed] [Google Scholar]
  10. Dresler C. M., Jeevanandam M., Brennan M. F. Extremity blood flow in man: comparison between strain-gauge and capacitance plethysmography. Surgery. 1987 Jan;101(1):35–39. [PubMed] [Google Scholar]
  11. Forbes G. B., Brown M. R., Welle S. L., Lipinski B. A. Deliberate overfeeding in women and men: energy cost and composition of the weight gain. Br J Nutr. 1986 Jul;56(1):1–9. doi: 10.1079/bjn19860080. [DOI] [PubMed] [Google Scholar]
  12. Heslin M. J., Newman E., Wolf R. F., Pisters P. W., Brennan M. F. Effect of systemic hyperinsulinemia in cancer patients. Cancer Res. 1992 Jul 15;52(14):3845–3850. [PubMed] [Google Scholar]
  13. Meguid M. M., Meguid V. Preoperative identification of the surgical cancer patient in need of postoperative supportive total parenteral nutrition. Cancer. 1985 Jan 1;55(1 Suppl):258–262. doi: 10.1002/1097-0142(19850101)55:1+<258::aid-cncr2820551309>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  14. Müller J. M., Brenner U., Dienst C., Pichlmaier H. Preoperative parenteral feeding in patients with gastrointestinal carcinoma. Lancet. 1982 Jan 9;1(8263):68–71. doi: 10.1016/s0140-6736(82)90212-4. [DOI] [PubMed] [Google Scholar]
  15. Newman E., Heslin M. J., Wolf R. F., Pisters P. W., Brennan M. F. The effect of insulin on glucose and protein metabolism in the forearm of cancer patients. Surg Oncol. 1992 Aug;1(4):257–267. doi: 10.1016/0960-7404(92)90086-z. [DOI] [PubMed] [Google Scholar]
  16. Ng E. H., Rock C. S., Lazarus D., Staiano-Coico L., Fischer E., Moldawer L. L., Lowry S. F. Impact of exogenous growth hormone on host preservation and tumor cell-cycle distribution in a rat sarcoma model. J Surg Res. 1991 Aug;51(2):99–105. doi: 10.1016/0022-4804(91)90077-y. [DOI] [PubMed] [Google Scholar]
  17. Pearlstone D. B., Wolf R. F., Berman R. S., Burt M., Brennan M. F. Effect of systemic insulin on protein kinetics in postoperative cancer patients. Ann Surg Oncol. 1994 Jul;1(4):321–332. doi: 10.1007/BF02303571. [DOI] [PubMed] [Google Scholar]
  18. Schwenk W. F., Beaufrere B., Haymond M. W. Use of reciprocal pool specific activities to model leucine metabolism in humans. Am J Physiol. 1985 Dec;249(6 Pt 1):E646–E650. doi: 10.1152/ajpendo.1985.249.6.E646. [DOI] [PubMed] [Google Scholar]
  19. Smale B. F., Mullen J. L., Buzby G. P., Rosato E. F. The efficacy of nutritional assessment and support in cancer surgery. Cancer. 1981 May 15;47(10):2375–2381. doi: 10.1002/1097-0142(19810515)47:10<2375::aid-cncr2820471009>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  20. Tayek J. A., Brasel J. A. Failure of anabolism in malnourished cancer patients receiving growth hormone: a clinical research center study. J Clin Endocrinol Metab. 1995 Jul;80(7):2082–2087. doi: 10.1210/jcem.80.7.7608259. [DOI] [PubMed] [Google Scholar]
  21. Thompson B. R., Julian T. B., Stremple J. F. Perioperative total parenteral nutrition in patients with gastrointestinal cancer. J Surg Res. 1981 May;30(5):497–500. doi: 10.1016/0022-4804(81)90096-2. [DOI] [PubMed] [Google Scholar]
  22. Torosian M. H., Donoway R. B. Growth hormone inhibits tumor metastasis. Cancer. 1991 May 1;67(9):2280–2283. doi: 10.1002/1097-0142(19910501)67:9<2280::aid-cncr2820670912>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  23. Unger R. H. Glucagon and the insulin: glucagon ratio in diabetes and other catabolic illnesses. Diabetes. 1971 Dec;20(12):834–838. doi: 10.2337/diab.20.12.834. [DOI] [PubMed] [Google Scholar]
  24. Vara-Thorbeck R., Guerrero J. A., Ruiz-Requena M. E., Capitán J., Rodriguez M., Rosell J., Mekinassi K., Maldonado M., Martin R. Effects of growth hormone in patients receiving total parenteral nutrition following major gastrointestinal surgery. Hepatogastroenterology. 1992 Jun;39(3):270–272. [PubMed] [Google Scholar]
  25. Wolf R. F., Ng B., Weksler B., Burt M., Brennan M. F. Effect of growth hormone on tumor and host in an animal model. Ann Surg Oncol. 1994 Jul;1(4):314–320. doi: 10.1007/BF02303570. [DOI] [PubMed] [Google Scholar]
  26. Wolf R. F., Pearlstone D. B., Newman E., Heslin M. J., Gonenne A., Burt M. E., Brennan M. F. Growth hormone and insulin reverse net whole body and skeletal muscle protein catabolism in cancer patients. Ann Surg. 1992 Sep;216(3):280–290. doi: 10.1097/00000658-199209000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wolfe B. M., Culebras J. M., Aoki T. T., O'Connor N. E., Finley R. J., Kaczowka A., Moore F. D. The effects of glucagon on protein metabolism in normal man. Surgery. 1979 Aug;86(2):248–257. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES